跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Spalax - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Spalax
Approved
STANDARD
Spalax
Sapphire Lifesciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e1052ebc03bf42ed
Company
Sapphire Lifesciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
e1052ebc03bf42ed
Drug Approval Philippines Name
Spalax
Product Name
Spalax
Registration Number
DRP-8477-02
Brand Name
Spalax
Generic Name
Hyoscine N-Butylbromide
Dosage Form
Film-Coated Tablet
Dosage Strength
10 mg
Manufacturer
Sapphire Lifesciences Pvt. Ltd.
Importer
Nelpa Lifesciences, Inc
Distributor
Kaufmann Pharma Inc
Issuance Date
26 September 2023
Expiry Date
16 May 2027
Pharmacologic Category
Anticholinergic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e1052ebc03bf42ed
Type
Standard
Back to Philippines FDA Approvals